BIOBV — Biohit Oyj Income Statement
0.000.00%
Last trade - 00:00
- €32.47m
- €28.17m
- €13.08m
- 78
- 34
- 69
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.1 | 7.12 | 9.36 | 11 | 13.1 |
Cost of Revenue | |||||
Gross Profit | 6.67 | 3.96 | 5.92 | 7.11 | 8.46 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 11.5 | 10.3 | 10.8 | 9.82 | 11.3 |
Operating Profit | -1.41 | -3.17 | -1.48 | 1.13 | 1.82 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.23 | -3.26 | -1.3 | 0.868 | 2.19 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.42 | -3.31 | -1.5 | 0.601 | 1.85 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.42 | -3.31 | -1.5 | 0.601 | 1.85 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.42 | -3.31 | -1.5 | 0.601 | 1.85 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.094 | -0.22 | -0.1 | 0.04 | 0.122 |
Dividends per Share |